NewGenIvf Group Ltd

An investment holding company headquartered in Bangkok, NewGenIvf Group Limited operates a network of fertility clinics across Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a comprehensive range of assisted reproductive services, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), embryo culture, chromosome screening, and egg freezing. Diagnostic services encompass hormonal blood testing, infectious disease screening, sperm analysis, washing, and freezing. The company also offers surrogacy services bundled with ancillary care to surrogate mothers, including regular health monitoring and pharmaceutical support.

Beyond core fertility treatments, NewGenIvf generates revenue through value-added services such as nutritional guidance, psychological counseling, acupuncture, and translation services, which complement primary treatment offerings. The company operates its services directly through owned clinic facilities rather than through franchise or third-party arrangements.

The company operates with approximately 76 full-time employees and was founded in 2010. It is incorporated in the British Virgin Islands and maintains a listing on Nasdaq, positioning it within the broader medical services sector focused on fertility treatments across Southeast Asia and Central Asia.